A validated HPLC method for the determination of vitamin K in human serum-first application in a pharmacological study

Open Clinical Chemistry Journal

Volumn 4, Issue 1, 2011, Pages 17-27

  Marinova, Milka ^a,b   Lütjohann, Dieter ^b   Westhofen, Philipp ^a   Watzka, Matthias ^a   Breuer, Olof ^b   Oldenburg, Johannes ^a  

^a UNIVERSITY OF BONN   (Germany)

^b UNIVERSITY HOSPITAL BONN   (Germany)

Author keywords

Chromatography; Coagulation; Konakion; Lipids; Menaquinone 4; Pharmacokinetics; Phylloquinone

Indexed keywords

MENATETRENONE; PHYTOMENADIONE;

ACCURACY; ADULT; AREA UNDER THE CURVE; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; DRUG BIOAVAILABILITY; DRUG CLEARANCE; DRUG HALF LIFE; DRUG STABILITY; DRUG STRUCTURE; FEMALE; FLUORESCENCE; HUMAN; HUMAN EXPERIMENT; MALE; MAXIMUM PLASMA CONCENTRATION; NORMAL HUMAN; PRIORITY JOURNAL; QUALITY CONTROL; RELIABILITY; REPRODUCIBILITY; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; SENSITIVITY AND SPECIFICITY; SINGLE DRUG DOSE; TIME TO MAXIMUM PLASMA CONCENTRATION; VARIANCE; VITAMIN BLOOD LEVEL; VITAMIN K METABOLISM;

EID: 80053478049     PISSN: None     EISSN: 18742416     Source Type: Journal    
DOI: 10.2174/1874241601104010017     Document Type: Article

References (43)

1. Shearer, M. J.; Vitamin, K. Lancet, 1995, 345(8944), 229-234.
2. Shearer, M. J. Role of vitamin K and Gla proteins in the pathophysiology of osteoporosis and vascular calcification. Curr. Opin. Clin. Nutr. Metab. Care, 2000, 3(6), 433-438.
3. Furie, B.; Furie, B. C. Molecular basis of vitamin K-dependent gamma-carboxylation. Blood, 1990, 75(9), 1753-1762.
4. Oldenburg, J.; Marinova, M.; Muller-Reible, C.; Watzka, M. The vitamin K cycle. Vitam. Horm., 2008, 78, 35-62.
5. Oldenburg, J.; Watzka, M.; Rost, S.; Muller, C. R. VKORC1: molecular target of coumarins. J. Thromb. Haemost., 2007, 5(Suppl 1), 1-6.
6. Rost, S.; Fregin, A.; Ivaskevicius, V.; Conzelmann, E.; Hortnagel, K.; Pelz, H. J.; Lappegard, K.; Seifried, E.; Scharrer, I.; Tuddenham, E. G.; Muller, C. R.; Strom, T. M.; Oldenburg, J. Mutations in VKORC1 cause warfarin resistance and multiple coagulation factor deficiency type 2. Nature, 2004, 427(6974), 537-541.
7. Shapiro, A. D.; Jacobson, L. J.; Armon, M. E.; Manco-Johnson, M. J.; Hulac, P.; Lane, P. A.; Hathaway, W. E. Vitamin K deficiency in the newborn infant: prevalence and perinatal risk factors. J. Pediatr., 1986, 109(4), 675-680.
8. Suttie, J. W. Vitamin K and human nutrition. J. Am. Diet. Assoc., 1992, 92(5), 585-590.
9. Thijssen, H. H.; Vervoort, L. M.; Schurgers, L. J.; Shearer, M. J. Menadione is a metabolite of oral vitamin K. Br. J. Nutr., 2006, 95(2), 260-266.
10. Davidson, R. T.; Foley, A. L.; Engelke, J. A.; Suttie, J. W. Conversion of dietary phylloquinone to tissue menaquinone-4 in rats is not dependent on gut bacteria. J. Nutr., 1998, 128(2), 220-223.
11. Shearer, M. J.; McBurney, A.; Barkhan, P. Studies on the absorption and metabolism of phylloquinone (vitamin K1) in man. Vitam. Horm., 1974, 32, 513-542.
12. Savage, D.; Lindenbaum, J. Clinical and experimental human vitamin K deficiency. 1983, 271-320.
13. Kohlmeier, M.; Saupe, J.; Drossel, H. J.; Shearer, M. J. Variation of phylloquinone (vitamin K1) concentrations in hemodialysis patients. Thromb. Haemost., 1995, 74, (5), 1252-1254.
14. Lamon-Fava, S.; Sadowski, J. A.; Davidson, K. W.; O'Brien, M. E.; McNamara, J. R.; Schaefer, E. J. Plasma lipoproteins as carriers of phylloquinone (vitamin K1) in humans. Am. J. Clin. Nutr., 1998, 67(6), 1226-1231.
15. Schurgers, L. J.; Vermeer, C. Differential lipoprotein transport pathways of K-vitamins in healthy subjects. Biochim. Biophys. Acta, 2002, 1570(1), 27-32.
16. Roche Konakion MM 2 mg. Fachinformation, 2007.
17. Roche Konakion MM 10 mg. Fachinformation, 2007.
18. Booth, S.; Tucker, K.; McKeown, N.; Davidson, K.; Dallal, G.; Sadowski, J. Relationships between dietary intakes and fasting plasma concentrations of fat-soluble vitamins in humans. J. Nutr., 1997, 127(4), 587-592.
19. Sadowski, J. A.; Hood, S. J.; Dallal, G. E.; Garry, P. J. Phylloquinone in plasma from elderly and young adults: factors influencing its concentration. Am. J. Clin. Nutr., 1989, 50(1), 100-108.
20. Haroon, Y.; Bacon, D. S.; Sadowski, J. A. Liquid-chromatographic determination of vitamin K1 in plasma, with fluorometric detection. Clin. Chem., 1986, 32(10), 1925-1929.
21. Dolnikowski, G. G.; Sun, Z.; Grusak, M. A.; Peterson, J. W.; Booth, S. L. HPLC and GC/MS determination of deuterated vitamin K (phylloquinone) in human serum after ingestion of deuterium-labeled broccoli. J. Nutr. Biochem., 2002, 13(3), 168-174.
22. Haroon, Y.; Bacon, D. S.; Sadowski, J. A. Chemical reduction system for the detection of phylloquinone (vitamin K1) and menaquinones (vitamin K2). J. Chromatogr., 1987, 384, 383-389.
23. Koivu-Tikkanen, T. J.; Ollilainen, V.; Piironen, V. I. Determination of phylloquinone and menaquinones in animal products with fluorescence detection after postcolumn reduction with metallic zinc. J. Agric. Food Chem., 2000, 48(12), 6325-6331.
24. Lutjohann, D.; Stroick, M.; Bertsch, T.; Kuhl, S.; Lindenthal, B.; Thelen, K.; Andersson, U.; Bjorkhem, I.; Bergmann Kv, K.; Fassbender, K. High doses of simvastatin, pravastatin, and cholesterol reduce brain cholesterol synthesis in guinea pigs. Steroids, 2004, 69(6), 431-438.
25. FDA Bioanalytical Method Validation. 2001.
26. Shah, V. P.; Midha, K. K.; Findlay, J. W.; Hill, H. M.; Hulse, J. D.; McGilveray, I. J.; McKay, G.; Miller, K. J.; Patnaik, R. N.; Powell, M. L.; Tonelli, A.; Viswanathan, C. T.; Yacobi, A. Bioanalytical method validation-a revisit with a decade of progress. Pharm. Res., 2000, 17(12), 1551-1557.
27. Card, D. J.; Shearer, M. J.; Schurgers, L. J.; Harrington, D. J. The external quality assurance of phylloquinone (vitamin K(1) analysis in human serum. Biomed. Chromatogr., 2009, 23(12), 1276-1282.
28. Langenberg, J. P.; Tjaden, U. R. Determination of (endogenous) vitamin K1 in human plasma by reversed-phase high-performance liquid chromatography using fluorometric detection after postcolumn electrochemical reduction. Comparison with ultraviolet, single and dual electrochemical detection. J. Chromatogr., 1984, 305(1), 61-72.
29. Shearer, M. J. Assay of K vitamins in tissues by high-performance liquid chromatography with special reference to ultraviolet detection. Methods Enzymol., 1986, 123, 235-51.
30. McCarthy, P. T.; Harrington, D. J.; Shearer, M. J. Assay of phylloquinone in plasma by high-performance liquid chromatography with electrochemical detection. Methods Enzymol., 1997, 282, 421-33.
31. Fu, X.; Peterson, J. W.; Hdeib, M.; Booth, S. L.; Grusak, M. A.; Lichtenstein, A. H.; Dolnikowski, G. G. Measurement of deuterium-labeled phylloquinone in plasma by high-performance liquid chromatography/mass spectrometry. Anal. Chem., 2009, 81, (13), 5421-5.
32. Davidson, K. W.; Sadowski, J. A. Determination of vitamin K compounds in plasma or serum by high-performance liquid chromatography using postcolumn chemical reduction and fluorimetric detection. Methods Enzymol., 1997, 282, 408-21.
33. Wang, L. Y.; Bates, C. J.; Yan, L.; Harrington, D. J.; Shearer, M. J.; Prentice, A. Determination of phylloquinone (vitamin K1) in plasma and serum by HPLC with fluorescence detection. Clin. Chim. Acta, 2004, 347(1-2), 199-207.
34. Azharuddin, M. K.; O'Reilly D. S.; Gray, A.; Talwar, D. HPLC method for plasma vitamin k1: effect of plasma triglyceride and acute-phase response on circulating concentrations. Clin. Chem., 2007, 53(9), 1706-13.
35. Soedirman, J. R.; De Bruijn, E. A.; Maes, R. A.; Hanck, A.; Gruter, J. Pharmacokinetics and tolerance of intravenous and intramuscular phylloquinone (vitamin K1) mixed micelles formulation. Br. J. Clin. Pharmacol., 1996, 41(6), 517-23.
36. Jones, K. S.; Bluck, L. J.; Wang, L. Y.; Coward, W. A. A stable isotope method for the simultaneous measurement of vitamin K(1) (phylloquinone) kinetics and absorption. Eur. J. Clin. Nutr., 2008, 62(11), 1273-81.
37. Raith, W.; Fauler, G.; Pichler, G.; Muntean, W. Plasma concentrations after intravenous administration of phylloquinone (vitamin K(1) in preterm and sick neonates. Thromb. Res., 2000, 99(5), 467-72.
38. Pereira, S. P.; Rowbotham, D.; Fitt, S.; Shearer, M. J.; Wendon, J.; Williams, R. Pharmacokinetics and efficacy of oral versus intravenous mixed-micellar phylloquinone (vitamin K1) in severe acute liver disease. J. Hepatol., 2005, 42(3), 365-70.
39. Pereira, S. P.; Shearer, M. J.; Williams, R.; Mieli-Vergani, G. Intestinal absorption of mixed micellar phylloquinone (vitamin K1) is unreliable in infants with conjugated hyperbilirubinaemia: implications for oral prophylaxis of vitamin K deficiency bleeding. Arch. Dis. Child Fetal. Neonatal. Ed., 2003, 88(2), F113-8.
40. Choonara, I. A.; Scott, A. K.; Haynes, B. P.; Cholerton, S.; Breckenridge, A. M.; Park, B. K. Vitamin K1 metabolism in relation to pharmacodynamic response in anticoagulated patients. Br. J. Clin. Pharmacol., 1985, 20(6), 643-8.
41. Bjornsson, T. D.; Meffin, P. J.; Swezey, S. E.; Blaschke, T. F. Effects of clofibrate and warfarin alone and in combination on the disposition of vitamin K1. J. Pharmacol. Exp. Ther., 1979, 210(3), 322-6.
42. Bechthold, H. Untersuchungen zum Vitamin K1-Stoffwechsel beim Menschen, 1985.
43. Shearer, M. J.; Newman, P. Metabolism and cell biology of vitamin K. Thromb. Haemost., 2008, 100(4), 530-47.